Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer L Proper

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Research Synthesis Methods|December 4, 2023
Network meta analysis to predict the efficacy of an approved treatment in a new indicationJennifer L Proper, Haitao Chu, Purvi Prajapati, et al.
Critical Care Explorations|February 13, 2023
Patient Outcomes and Unit Composition With Transition to a High-Intensity ICU Staffing Model: A Before-and-After StudyJennifer L Proper, David A Wacker, Salma Shaker, et al.
JAMA|October 25, 2023
Sigh Ventilation in Patients With Trauma: The SiVent Randomized Clinical TrialRichard K Albert, Gregory J Jurkovich, John Connett, et al.
Open Forum Infectious Diseases|April 8, 2022
Vaccination Against SARS-CoV-2 Is Associated With a Lower Viral Load and Likelihood of Systemic SymptomsCarolyn T Bramante, Jennifer L Proper, David R Boulware, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2022
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT TrialDavid R Boulware, Thomas A Murray, Jennifer L Proper, et al.
The Lancet. Infectious Diseases|June 11, 2023
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trialCarolyn T Bramante, John B Buse, David M Liebovitz, et al.
The New England Journal of Medicine|September 7, 2022
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19Carolyn T Bramante, Jared D Huling, Christopher J Tignanelli, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Research Synthesis Methods|December 4, 2023
Network meta analysis to predict the efficacy of an approved treatment in a new indicationJennifer L Proper, Haitao Chu, Purvi Prajapati, et al.
Critical Care Explorations|February 13, 2023
Patient Outcomes and Unit Composition With Transition to a High-Intensity ICU Staffing Model: A Before-and-After StudyJennifer L Proper, David A Wacker, Salma Shaker, et al.
JAMA|October 25, 2023
Sigh Ventilation in Patients With Trauma: The SiVent Randomized Clinical TrialRichard K Albert, Gregory J Jurkovich, John Connett, et al.
Open Forum Infectious Diseases|April 8, 2022
Vaccination Against SARS-CoV-2 Is Associated With a Lower Viral Load and Likelihood of Systemic SymptomsCarolyn T Bramante, Jennifer L Proper, David R Boulware, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2022
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT TrialDavid R Boulware, Thomas A Murray, Jennifer L Proper, et al.
The Lancet. Infectious Diseases|June 11, 2023
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trialCarolyn T Bramante, John B Buse, David M Liebovitz, et al.
The New England Journal of Medicine|September 7, 2022
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19Carolyn T Bramante, Jared D Huling, Christopher J Tignanelli, et al.
Pageof 1